This inventor holds 1 USPTO granted patent. Top assignee: Spartan Bioscience Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Jamie Spiegelman: Innovator in Nucleic Acid Amplification Technology
Introduction
Jamie Spiegelman is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid amplification. Her innovative work has led to the development of a patented system that enhances the efficiency of nucleic acid detection.
Latest Patents
Jamie Spiegelman holds a patent for a "System for rapid nucleic acid amplification and detection." This technology involves a temperature cycling system designed for repeatedly heating and cooling a reaction mixture. The system includes a first heater and a second heater, each of which can be moved between two orientations. In the first orientation, the heaters affect the temperature of the reaction mixture, while in the second orientation, they do not substantially affect the temperature. This innovative approach allows for effective temperature cycling, optimizing the nucleic acid amplification process.
Career Highlights
Jamie is currently employed at Spartan Bioscience Inc., where she continues to advance her research and development efforts. Her work at Spartan has positioned her as a key player in the biotechnology sector, contributing to the company's mission of improving diagnostic technologies.
Collaborations
Jamie has collaborated with notable colleagues, including Paul Lem and John Lem. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.
Conclusion
Jamie Spiegelman is a pioneering inventor whose work in nucleic acid amplification technology has the potential to revolutionize diagnostic processes. Her contributions to Spartan Bioscience Inc. and her innovative patent reflect her commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile